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Abstract 
 
Odontogenesis has been extensively studied to ascertain the cellular pathways and 
biochemical signals that help to regulate this developmental system. Various gene 
families and growth factors that been identified as important regulators of tooth 
development. However other molecules such as retinoic acid and PI3K have also been 
implicated in the regulation of tooth development, especially in the initiation stage of 
tooth development and cusp morphogenesis. By inhibiting RA synthesis with citral, and 
PI3K activation using wortmannin, the study sought to investigate how amelogenesis and 
cusp morphogenesis were affected in murine developing first mandibular molars.  Tooth 
development of the 14.5 and 16.5 day embryonic mouse, in vitro for 12 days, did not 
progress beyond the early bell stage. This was indicated by the absence of an enamel 
layer and possible remnant basement membrane in the cultured molars. Furthermore, no 
deviations in cusp morphology were observed, when inhibitors against either RA or PI3K 
were applied. However utilizing QRT-PCR, it was noted that the synthesis of 
amelogenin-mRNA increased in the 14.5 day tooth explants treated with citral, but not in 
the 16.5 day molar explants subjected to the same treatment. These results could 
therefore suggest that the degradative pathways or feedback systems controlling 
amelogenin-mRNA levels are inactive prior to the onset of amelogenesis on day 15-16. 
On the other hand, PI3K did not appear to regulate amelogenin expression, in either 14.5 
or 16.5 day embryonic mouse molar explants that were treated with wortmannin. 
Statistical analysis revealed no changes in the laminin α5-mRNA levels in either 14.5 or 
16.5 day molars treated with either citral or wortmannin, which suggests that PI3K is not 
the only cellular pathway that controls laminin-mRNA synthesis.  
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1. Introduction 
1.1 Tooth development 
The mechanism of tooth formation is a highly conserved event in the vertebrate kingdom. 
Derived from stomodeal ectodermal cells of the first pharyngeal arch and 
ectomesenchyme of the cranial neural crest (Cobourne, 1999; Cobourne and Sharpe, 
2003), the teeth develop prenatally, advancing through a chain of morphological stages 
i.e. bud stage, cap stage and bell stage (Apajalahti, 2004). During these stages, several 
distinct molecular pathways and processes become active, which are required for normal 
tooth formation. During infancy, the teeth will erupt from their “incubation chambers” of 
the maxillary and mandibular arches. During this process, the apical regions are anchored 
into the alveolar bone of the maxilla and mandible in order to be nourished and 
maintained (Apajalahti, 2004). 
 
1.1.1 Important morphological events of mouse tooth development: 
A.) Initiation stage (Day 10-11) 
The initiation stage or dental lamina stage (Fig. 1A) is characterized by the appearance of 
a continuous band of oral epithelium which forms a horseshoe-shaped thickening along 
the surfaces of the maxillary and mandibular arches (Moss-Salentijn and Hendricks-
Klyvert, 1990). The dental lamina, which gives rise to the teeth, is derived initially from 
the primary epithelial band (Teaford et al., 2000).  
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B.) Bud stage (Day 12-13) 
The bud stage (Fig. 1B) is characterized by the appearance of an ectodermal bud, which 
develops from the dental lamina and has no clear cellular arrangement.  The dental 
lamina invades the ectomesenchyme by forming a structure that is rod-like in appearance. 
These “rods” develop in the position of the future teeth becoming bulbous at their deep 
ends. They are surrounded by condensed ectomesenchyme. The ectomesenchyme will 
eventually form the dental follicle and dental papilla (Cohn 1957).  
 
C.) Cap stage (Day 13-14) 
The first sign of an arrangement of cells in the developing tooth occurs in the cap stage 
(Fig. 1C) when the bud separates into two layers, the outer and inner enamel epithelium 
(Cohn 1957). A blunt angle is created near the junction of the outer and inner enamel 
epithelial layers, which is referred to as the cervical loop from which the root will form. 
The residual cellular components of the cap, which occupy the space between the outer 
and inner enamel epithelia, develop into the stellate reticulum. Thus the enamel organ, 
which is ultimately responsible for the production of enamel, is composed of inner and 
outer enamel epithelia and the stellate reticulum. Forming part of the inner enamel 
epithelium is the primary enamel knot, consisting of non-dividing cells that act as a cell 
reservoir for the fast-growing enamel organ. This structural knot also serves as an 
important signalling centre for expressing various growth factors and messenger 
molecules, of which FGF-4 is the most important (Miletich and Sharpe, 2003). These 
factors and molecules are necessary for initiating central processes such as amelogenesis.  
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As tooth development progresses, the primary enamel knot undergoes apoptosis and is 
replaced by secondary enamel knots. Simultaneously the dental papilla and dental follicle 
positioned around the bud undergo further condensation with the dental papilla indenting 
the shallow surface of the bud, forming a “cap” that promotes the elongation of the 
cervical loop.  
 
D.) Bell stage (Day 15-16)  
During the bell stage (Fig. 1D) or differentiation stage, both morphogenesis and 
cytodifferentiation take place (Moss-Salentijn and Hendricks-Klyvert, 1990), which gives 
rise to the shape and structure of the tooth. The inner enamel epithelial cells reverse their 
polarity due to induction by the ectomesenchyme of the dental papilla. The nuclei of 
these cells relocate towards the apical pole of the cell which is situated away from the 
basement membrane. Upon polarization, inner enamel epithelial cells stimulate the 
underlying ectomesenchymal cells of the dental papilla to differentiate into odontoblasts. 
The odontoblasts then start to secrete dentin and in turn stimulate the inner enamel 
epithelial cells to differentiate into ameloblasts. Cells lying between the inner enamel 
epithelium and the stellate reticulum form a layer known as the stratum intermedium, 
which is believed to assist ameloblasts with enamel formation (Koyama et al., 2001). 
During the bell stage, secondary enamel knots appear which are similar in function to the 
primary enamel knot, except that they occur in multi-cusped teeth i.e. molars, to assist 
with the formation of the cusps. 
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Stage and embryonic day Main process involved 
A.) Initiation stage – Embryonic day 10-11 
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B.) Bud stage – Embryonic day 12-13 
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C.) Cap stage – Embryonic day 13-14 
 
 
 
Proliferation, differentiation, 
morphogenesis 
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Figure 1. Diagrammatic representations of the important stages of tooth development (an 
adjustment from images used by Gilbert (1994))   
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1.1.2 Amelogenesis 
Amelogenesis or enamel formation occurs during the bell stage of tooth development on 
embryonic days (E) 15-16 in the mouse (Zeichner-David et al., 1995). First the cuboidal 
cells of the inner enamel epithelium stop dividing. The cells of the inner enamel 
epithelium then start to elongate and become more columnar in shape and their nuclei 
migrate to the part of the cell located away from the basement membrane. Classified as 
pre-ameloblasts, they stimulate the peripheral cells of the dental papilla to differentiate 
into odontoblasts via an unknown extracellular signal (Moss-Salentijn and Hendricks-
Klyvert, 1990). The odontoblasts aggregate into a single layer near the basement 
membrane and, similarly to the pre-ameloblasts, become polarized (i.e. their nuclei move 
away from basement membrane). They are incapable of undergoing mitosis and all the 
organelles for protein synthesis migrate towards the space of the cell facing the basement 
membrane (Moss-Salentijn and Hendricks-Klyvert, 1990). Once odontoblasts have 
differentiated and have started synthesizing dentin matrix (Moss-Salentijn and 
Hendricks-Klyvert, 1990) an unknown messenger molecule is relayed back to the pre-
ameloblasts, through the basement membrane, causing the pre-ameloblasts to 
differentiate into ameloblasts. As this transition occurs the basement membrane is slowly 
degraded to allow for a connection between the dentin and enamel matrices (Moss-
Salentijn and Hendricks-Klyvert, 1990). The ameloblasts then initiate the process of 
enamel formation, which can be categorized into three stages: 
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1) Secretory stage of amelogenesis  
In the secretory stage of amelogenesis in mouse, specific enamel matrix proteins 
are released from the rough endoplasmic reticulum of the ameloblasts. These are 
then secreted by the Tomes process, situated at the apical tip of the polarized 
ameloblasts, into the extracellular matrix located opposite to the developing 
dentin matrix. This enamel matrix comprises several scaffolding proteins, of 
which 90% are amelogenin (Stephanopoulos et al., 2005) and the residual consists 
of ameloblastin, enamelin and tuftelin, which are essential proteins upon which 
the final mineralization process takes place. Before these proteins are released 
into the enamel matrix they are post-translationally modified by proteolytic 
enzymes through cleavage of either the N- or C-terminal of their amino acid 
peptides (Stephanopoulos et al., 2005). The enamel matrix proteins maintain their 
structural arrangement until the mineralization or maturation stage commences, 
which starts after a short intermediate step, i.e. the transition stage.    
 
2) Transition stage 
As this stage implies, it is a short period at the end of the secretory stage when 
50% of the ameloblast cell numbers are reduced by apoptosis (Moss-Salentijn and 
Hendricks-Klyvert, 1990; Avery, 2001). Furthermore, ameloblasts lose their 
organelles for protein synthesis, such as the Golgi apparatus, and undergo 
morphological changes which transform them from a secretory cell into one 
similar to an epithelial cell involved in ion transport (Avery, 2001).   
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3) Maturation stage of amelogenesis 
The maturation stage is characterized by the enamel matrix becoming fully 
mineralized (Avery, 2001). The majority of the amelogenin, ameloblastin, 
enamelin and water (organic) is degraded and is replaced with hydroxyappatite 
crystals including calcium-and phosphate ions (inorganic) which accumulate in 
the spaces left by the organic matrix. The maturation is an ongoing process that 
begins as soon as some enamel matrix has been formed (Moss-Salentijn and 
Hendricks-Klyvert, 1990). Yet, the complete maturation of enamel is only 
achieved once all mineralization has occurred and almost all the organic 
molecules in the enamel have been removed (Avery, 2001).   
 
1.2 Identification of genes involved in tooth development 
Although the morpho-, histo- and cytogenesis of the tooth have been well documented, 
the underlying biochemical signalling pathways controlling tooth development have not 
yet been fully elucidated. Currently, scientific studies are being conducted in an effort to 
determine genes and gene products that activate and regulate odontogenesis. These 
studies include specific processes in odontogenesis such as amelogenesis and/or 
dentinogenesis. Genes which have been identified as important in odontogenesis, 
especially during the cap and bell stage are, for example, Dlx-, Msx-, Bmp- and the Notch 
families (Mitsiadis et al., 1995; Cobourne, 1999; Stephanopoulos et al., 2005) including 
structural genes coding for amelogenin, amelotin, ameloblastin, enamelin, KLK-4 and 
enamelysin (Fukumoto et al., 2004; Iwasaki et al., 2005; Stephanopoulos et al., 2005; 
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Torres-Quintana et al., 2005). Various growth factors have also been identified which 
contribute to tooth development, such as epidermal growth factor (EGF) and fibroblast 
growth factor (FGF), which are essential for the initiation of tooth formation (Kronmiller 
et al., 1995a; 1995b; Cobourne and Sharpe, 2003). Retinoic acid (RA) has also been 
suggested as important in the initiation and patterning of odontogenesis (Kronmiller et 
al., 1995a).  Amongst its functions, RA is said to promote the expression of different 
genes that are involved in terminal differentiation of specific cells (Mitsiadis et al., 1995; 
Kronmiller et al., 1995b; Berkovitz et al., 2001) such as ameloblasts. 
 
1.2.1 Retinoic acid and tooth formation 
Retinoic acid (RA), a derivative of retinol (vitamin A), is manufactured from the 
oxidative reaction when retinol is converted to RA via specific retinoic acid-synthesizing 
enzymes 1, 2, and 3 (Berkovitz et al., 2001; Niederreither et al., 2002). RA is able to 
associate with specific nuclear receptors (retinoic acid receptors) (Huq et al., 2007), 
which are transcription factors regulating a diverse number of genes. RA is also able to 
upregulate the production of the EGF receptor (Kronmiller et al., 1995a) and its ligand 
EGF, which are important initiation factors required for tooth development. Kronmiller et 
al. (1995a) showed that RA peaks early (at E11.5) in mice, the same stage during which 
dental lamina formation is initiated. They found that a loss of RA prevented correct 
dental lamina formation and normal tooth morphology. Furthermore, when exogenous 
RA was added in vitro to E11.5 embryonic mouse molars, the development of 
supernumary tooth buds occurred (Kronmiller et al., 1995a). RA is spatially distributed 
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from the region of the incisors (lowest) to the molars (highest) (Kronmiller et al., 1995a), 
thus forming a concentration gradient across the maxilla and mandible. It is this 
concentration gradient which is said to regulate the initiation of tooth development at 
particular time intervals during embryogenesis. RA was also found to upregulate Notch 
genes, which provided insight into how tissue patterning in the tooth could occur 
(Mitsiadis et al., 1995). 
Notch was first isolated, analyzed and sequenced from Drosophila melanogaster, before 
a homologue was found in humans and mice. Its function is related to the pathway of 
determining cell fate (Mitsiadis et al., 1995). Coffman et al. (1993) postulated that the 
role of Notch is to block cell transformation by maintaining the competence of 
undifferentiated cells until such time as differentiation proceeds. RA has been linked to 
upregulating Notch expression which consequently appears to prevent cells from terminal 
differentiation.  An example of this is during the formation of ameloblasts, where Notch 
is upregulated via RA until amelogenesis is to be initiated (Mitsiadis et al., 1995). During 
prenatal development RA levels drop to a specific concentration and Notch is 
downregulated (Mitsiadis et al., 1995) allowing previously undifferentiated cells to 
change into ameloblasts.  
 
1.2.2 Citral  
Citral (3, 7-dimethyl-2, 6-octadienal) was found to be a competitive inhibitor of RA, 
retinal and retinol by Schuh et al. (1993). Kronmiller et al. (1995a) further demonstrated 
the suppressing effects of citral when they showed that it could inhibit retinoic acid 
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synthesis and thus prevent the initiation of odontogenesis, specifically dental lamina 
formation. In their experiments Kronmiller et al. (1995a) also revealed that citral was 
able to inhibit all-trans-RA, yet none of the cis-RA groups. Thus Kronmiller et al. (1995a) 
proved that at E11.5, inhibition of RA synthesis (all-trans-RA) resulted in altered 
patterning of the dental lamina. These same authors stated that an addition of 0.04µM of 
all-trans-RA to the growth medium was able to partially rescue tooth formation from 
initial citral inhibition. However, no research was performed to see how citral-induced 
inhibition of RA affected the later stages, such as the cap stage (E14) or bell stage (E16) 
of tooth development and how this impacted crown morphology as well as amelogenesis. 
There is evidence which shows that RA is still present in lesser quantities in neonatal day 
5 mice in the region of the developing tooth, as the specific enzymes RALDH2 and 3 are 
still expressed long after the majority of the retinol had dissipated from the oral region 
(Niederreither et al., 2002). This indicates that there are still minor amounts of retinol 
present. Thus it is possible that RA still regulates genes after the bell stage, possibly even 
those of the Notch family, indicating a more specific role of RA in odontogenesis, other 
than just assisting in dental lamina formation and the initiation of tooth development.    
 
1.2.3 PI3-kinase, laminins and wortmannin 
Wortmannin, a naturally synthesized fungal metabolite derived from Penicillium 
fumiculosum, was used by Fukumoto et al. (2005) to show that phosphatidylinositol 3-
kinase (PI3K) inhibition resulted in altered cusp morphology of the tooth when applied to 
E12.5 to 14.5 day embryonic teeth. Platelet derived growth factor regulates PI3K 
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activation (Pedigo et al., 2007), which then controls laminin production via protein 
kinase B/Akt (Li et al., 2001). Laminins consist of three genetically distinct α, β and γ 
chains.  There are five α and three of each β and γ chains, which form 15 isoforms of 
laminin (laminin-1 to -15) with different sub-unit permutations (Fukumoto et al., 2005). 
Laminins make up the majority of the basement membrane, which is composed of two 
layers, i.e. an internal basal lamina and an external fibrillar reticular lamina (Sanes, 
2003). The external lamina is composed of fibrillar collagen whereas the basal lamina 
contains non-fibrillar collagen, together with non-collagenous glycoproteins, 
proteoglycans (Sanes, 2003) and laminins (Fukumoto et al., 2005). It is believed that 
some of the proteins, i.e. the laminins in the basal lamina, are key regulators in causing 
cells to become polarized and to stimulate cytodifferentiation of ameloblasts and 
odontoblasts (Moss-Salentijn and Hendricks-Klyvert, 1990). Laminins accomplish this by 
binding with specific cell surface receptors including integrins, syndecans and α-
dystroglycans, which regulate various biological activities including cell adhesion, 
migration, differentiation, angiogenesis and tumour metastasis (Fukumoto et al., 2005).  
An important member of the laminin family is the laminin α5 chain which is expressed in 
many fetal and adult tissues. Associating either with laminin chain γ1 or β2, which are 
the main constituents of the basement membrane (Yurchenco et al., 2004), to form 
laminin-10 or laminin-11, laminin α5 is able to regulate cell migration, nuclei polarity 
and cytodifferentiation of emerging cell lineages. When laminin α5 synthesis is perturbed 
via a PI3K/wortmannin interaction during mouse tooth development, cellular 
organization is lost and a malformation, such as altered cusp morphology, arises 
(Fukumoto et al., 2005).  However it is unclear whether the inhibition of PI3K affects 
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amelogenin mRNA expression during tooth development and how great the loss in 
laminin α5-mRNA levels must be to produce this alteration in cusp morphology. 
 
2. Aim  
The aim of this study was thus to investigate how amelogenesis and tooth morphology 
are affected during specific stages (cap and bell stage) of tooth development in vitro, 
when retinoic acid and PI3-kinase were inhibited by citral and wortmannin respectively. 
The first mandibular molar of the mouse was used as the model system for this 
experiment. 
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3. Materials and Methods 
3.1 Animals used in the study 
Animal ethics clearance for this experiment was obtained from the Animal Ethics 
Committee of the University of the Witwatersrand, Johannesburg, South Africa 
(Clearance Number 2006/17/01). 
Sixteen female NMRI x NMRI pregnant mice and two 6.5 day mouse pups were 
used in this research. Of the pregnant animals, eight were 14.5 days pregnant and 
eight were 16.5 days pregnant. The rationale for using 14.5 and 16.5 day pregnant 
mice was that on these days the first mandibular molars of embryonic mice would 
have entered the cap and bell stages respectively. Furthermore, at these two stages 
various genes become active which are important for cytodifferentiation, 
histogenesis and morphogenesis of the developing tooth. Therefore, any changes in 
tooth development may be most pronounced, when citral or wortmannin are applied 
during these two prenatal ages.       
Female NMRI x NMRI mice were mated with males of known fertility and the age 
of pregnancy was determined by the appearance of a vaginal plug on the morning 
following copulation. This was considered to be day 0.5 of pregnancy.  At the 
appropriate age of pregnancy i.e. either 14.5 days or 16.5 days, the mouse was 
removed from the animal unit. Animals were killed by a lethal injection of 0.4ml of 
Euthanase (Kyron Laboratories, Johannesburg). 
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3.2 Tooth extraction 
An incision was made in the abdominal region of each pregnant animal. The uterine 
horns containing the embryos were then removed and placed in a petri-dish in sterile 
Tyrode’s solution (Appendix A) containing 1% glucose and 100UI/ml 
penicillin/streptomycin. The container with the uterine horns was then placed in an 
incubator at 37oC.  
Under sterile conditions an embryo was excised from a uterine horn and placed into 
a black wax dish containing Tyrode’s solution (Fig. 2A). The murine embryos were 
then decapitated and the lower jaw was separated from the head (Fig. 2B and C). The 
lower jaw was then transferred on to a cavity block containing resin (Fig. 2D) and 
Tyrode’s solution. Utilizing both incident and transmitted light, the first mandibular 
molars were removed from either side of the jaw by micro-dissection (Fig. 2E). 
Extracted molars were then relocated into a glass cavity block containing Tyrode’s 
solution. This block was placed on to a 37oC heating plate for a short period of time 
to maintain cellular viability while explants were accumulated. 
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Figure 2. Photographic representation of micro-extraction procedure of first mandibular 
molars from 16.5 day old mouse embryos. The embryo was removed from the uterine horn 
and placed in a black wax dish (A) containing Tyrode’s solution and then decapitated (B). 
The mandible and maxilla were separated from each other (C) and the mandible was 
transferred into a resin-containing cavity block (D).The first mandibular molars were then 
dissected free of the jaw (E).  Note: A-C 25X stereomicroscope; D and E 40X 
stereomicroscope and transmitted light 
2A 2B 
2C 
2D 2E 
Mandible 
Maxilla 
1st mandibular molar 
Mandible 
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3.3 Organ culture 
Stainless steel rafts were placed into four-welled Nunc culture dishes (Microsep, 
Ireland). An Isopore membrane (Microsep, Ireland) manufactured at a pore size of 
0.05 µm was then positioned on each stainless steel raft. To each well 800 to 900µl 
of BGjb culture medium (Modified Fitton and Jackson medium supplemented with 
L-glutamine, GIBCO, South Africa), supplemented with 10% fetal calf serum (FCS), 
100µg/ml ascorbic acid and 100UI/ml pen/strep was added. For experimental 
explants, the culture medium was further augmented with either 1.75µM citral 
(Sigma-Aldrich, South Africa) or 20nM wortmannin (Sigma-Aldrich, South Africa), 
which are the optimal concentrations at which the inhibitors are said to operate 
(Kronmiller et al., 1995a; Stein and Waterfield, 2000). Three to four first mandibular 
molar explants were then placed onto each Isopore membrane. All explants were first 
cultured for a duration of 5-hours in a ThermoForma Series II water-jacketed CO2 
incubator (Labotec, South Africa) at 37oC and an atmosphere of 5% CO2 in air. The 
rationale for culturing explants for 5 hours in the presence of citral and wortmannin 
was to investigate whether changes in gene expression and cusp morphology could 
be altered in such a short time period as opposed to the reported exposure period of 
24 hours (Kronmiller et al.1995a; Fukumoto et al. 2005). After the initial 5-hour 
treatment with BGjb medium containing either citral or wortmannin, the medium 
was substituted with fresh BGjb medium supplemented with 10% FCS, 100µg/ml 
ascorbic acid and 100UI/ml pen/strep. Explants were left to develop for 12 days at 
37oC at 5% CO2 in air. The medium was changed every two days and explants were 
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examined for morphological variations with an Olympus inverted-phase contrast 
microscope. Photomicrographs were taken as necessary. 
3.4 Histological analysis of tooth explants 
3.4.1 Fixation of explants for sectioning 
Thirty-six tooth explants (12 controls (14.5n=6; 16.5n=6), 12 citral-treated (14.5n=6; 
16.5n=6) and 12 wortmannin-treated (14.5n=6; 16.5n=6)) were used for 
immunocytochemistry with two 6.5 postnatal mouse pup molars acting as positive 
controls. The remaining molar explants were utilized to analyze the general 
morphological and histological changes which may have occurred during the 12-day 
culture period and to compare the growth between control and treated molar 
explants. The teeth were recovered from the culture medium after 12 days and 
washed twice in 10% phosphate buffered saline (Appendix A). Explants were then 
fixed for 3 hours in 10 % buffered formalin (Appendix A), before being washed for 
30 minutes in 10% PBS. The explants were then dehydrated through a graded series 
of alcohols, after which they were transferred into xylene for clearing for 10 minutes. 
Explants were then transferred into paraffin wax and left overnight. The following 
morning the explants were blocked in fresh paraffin wax.  
 
3.4.2 Preparation of silane-coated glass slides 
Slides were cleansed overnight in a 10% Extran solution. These were then washed 
for 2 hours under running tap water, before being left to dry in a 60oC oven. Slides 
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were immersed in a 2% aminopropyltriethoxysilane (referred to as silane) solution 
for 30 minutes. They were then given two quick washes in acetone and one in 
distilled water. They were then allowed to dry in a 42oC incubator overnight.  
 
3.4.3 Immunocytochemistry 
Serial sections of the fixed first mandibular molar tissue were cut at either 5 or 10µm 
on a Reichert-Jung Microtome and mounted on to silane-coated slides. 
Approximately 15-30 sections were obtained from each explant, depending on the 
thickness of the section. The sections were briefly dried on a Raymond(a) Lamb slide 
dryer, before being left in a 42oC oven overnight. Sections were stored at room 
temperature until required. 
Every fifth or tenth section from each explant was stained with haematoxylin and 
eosin (Appendix A) for routine histological examination. The indirect 
immunocytochemical method was used to localize amelogenin and laminin. 
Localization was carried out on sections adjacent to from those stained with 
haematoxylin and eosin which showed clear tissue definition.   
For the localization of amelogenin and laminin, the sections were de-waxed in 
xylene and then hydrated through a graded series of alcohols to water. To block 
endogenous peroxidase, sections were incubated in 3% hydrogen peroxide for 10 
minutes at room temperature. Following rinsing in 10% PBS, sections were 
incubated in 10% non-immune swine serum for 10 minutes at room temperature to 
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prevent non-specific binding of the antisera. Sections were then sequentially 
incubated with the primary antibody, rabbit anti-mouse amelogenin (1:200, Kamiya 
Biomedical, Washington) or rabbit anti-mouse laminin (1:25, Sigma, South Africa) 
at 4oC overnight. Sections were then incubated with the secondary antibody (1:50 
swine anti-rabbit, Dako, Denmark) for 1 hour at room temperature. Peroxide anti-
peroxidase (PAP 1:100, Dako, Denmark) was then applied for 30 minutes, followed 
by a 5-minute incubation in diaminobenzide (DAB, BDH Laboratory Supplies, 
England) (Appendix A). Between the various incubations, sections were rinsed three 
times at 5 minutes each, in 10% PBS. All sections were viewed utilizing differential 
interference contrast microscopy (DIC) with the assistance of an Axioscope 2 
Microscope which uses the computer-based program AxioVision Rel. 4.5. Being an 
optical microscopy illumination technique, DIC, also known as Nomarski optics is 
used to enhance the contrast in unstained, transparent samples such as those obtained 
by ICC. 
3.4.4 Immunocytochemistry controls 
The respective antiserum was applied to sections, which originated either from serial 
sections of cultured molars or from mouse pup first mandibular molars. Two 
different control procedures were carried out: 
i) Negative controls were carried out on sections adjacent to those on which 
staining occurred, to test the specificity of the primary and secondary 
antisera. The primary (anti-amelogenin and anti-laminin) or secondary 
antiserum was replaced by 10% PBS or 1% swine serum. Replacing the 
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primary antiserum verifies that the immunolocalization is specific. Replacing 
the secondary antiserum, which carries the enzyme for the color substrate 
(DAB), confirms that there are no other endogenous enzymes reacting with 
the DAB. 
ii) Positive controls were included in each immunocytochemical run to ensure 
the validity of the immunocytochemical technique itself. Sections from the 
first mandibular molar of a 6.5 day old NMRI mouse pup, known to be 
positive for the amelogenin antigen, and an adult mouse kidney (Animal 
Ethic clearance number 2006/17/01), known to be positive for the laminin 
antigen, were included in each run. 
 
3.5 Amelogenin and laminin α5 gene expression in tooth explants 
3.5.1 Primer design 
Sequences of mouse amelogenin and laminin genes were researched on 
www.pubmed.com. Once an appropriate sequence had been found (~1kbp), forward 
and reverse primers were created (Table 1) to amplify a specific region within this 
sequence that was unique. This was determined by utilizing BLAST 
(www.pubmed.com) to cross-reference the primers to other sequences on the 
Pubmed databank. This ensured that the designated primers specifically amplified 
only the selected sequence. A second forward primer was also created that was 
localized within the first forward primer. In this way, a nested polymerase chain 
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reaction could be utilized, to increase the efficacy of amplification, by ensuring that 
only the sequence of choice was produced. Inqaba Biotech Laboratories, South 
Africa, then manufactured these sets of primers 
 
Table 1. Primers for the amelogenin and the laminin gene 
 
   
3.5.2 RNA extraction using the RNeasy ® Micro Kit 
Thirty-six random tooth explants [12 controls (6x14.5 day; 6x16.5 day), 12 citral-
treated (6x14.5 day; 6x16.5 day), 12 wortmannin-treated (6x14.5 day; 6x16.5 day)] 
were used for RNA extraction (RNeasy ® Micro kit Quiagen, South Africa), 
complementary DNA synthesis and subsequent PCR/Real-time PCR. On the day of 
the RNA extraction, explants were retrieved from the culture medium and washed in 
de-ionized water for 2 minutes.  Each explant was then transferred into a QIA 
shredder Spin Column (Quiagen, South Africa). To assist with the lysis and 
homogenization of the tissue, 350µl of a β-mercaptaethanol/buffer RLT solution was 
added and microfuged for 3 minutes. The supernatant was transferred into a new 2ml 
Primer Name and direction 
 
Primer sequence 
Amelogenin Forward 1 TTTTGCTATGCCCCTACCAC 
Amelogenin Forward 2 TACCACCTCATCCTGGAAGC 
Amelogenin Reverse ATGAGGCTGAAGGGTGTGAC 
Laminin Forward 1 GTGGGGAGAGGGTACCTGAT 
Laminin Reverse  TCTTGGGGGACACCTTGATA 
Β-actin Forward TGATGGACTCCGGTGACGG 
Β-actin Reverse TGTCACGCACGATTTCCCGC 
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collection tube, to which 350µl of 70% ethanol was added to precipitate out DNA 
and cellular proteins. This mixture was immediately placed into RNeasy® MinElute 
Spin Column (Quiagen, South Africa) and centrifuged at maximum velocity for 15 
seconds. The flow-through was discarded and 700 µl of buffer RW1 was added to 
denature all enzymes including RNase and DNase. Once this had been microfuged 
for 15 seconds, the 2ml collection tube was replaced and 500 µl of buffer RPE was 
added to the column for washing. After 15 seconds of microfugation, 500 µl of 80% 
ethanol was added to dry the column. This was then centrifuged for 2 minutes and 
both supernatant and the 2ml collection tube were discarded.  The RNeasy® 
MinElute Spin Column was then transferred into a 1.5ml autoclaved eppendorf tube. 
The extracted RNA was then eluted by adding 50 - 100µl of RNase-free water to the 
column and microfuging for 2 minutes. The concentration and quality of the extract 
was measured by the use of a Nano-drop Spectrophotometer, Series ND-100. 
Samples were stored at -70oC for further use. 
 
3.5.3 cDNA synthesis using a Reverse Transcription PCR kit  
Samples containing the extracted RNA from the first mandibular molar explants 
were taken from the -70oC freezer and thawed on ice. Once the samples had 
liquefied, 1-5µl of RNA was added to 11µl of DEPL-treated water (Inqaba Biotech, 
South Africa) in a 0.5µl eppendorf tube. This was further augmented with 1µl of the 
oligod (T) primer (kit), tapped gently before being spun down, and left in a heating 
block set at 70oC for 5 minutes, to denature any residual enzyme activity that could 
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interfere with the reverse transcriptase. The eppendorf tube was then placed back on 
ice and allowed to cool, after which 4µl 5x reaction buffer (kit), 2µl 10mM dNTP 
mix (kit) and 1µl Ribolock ribonuclease (kit) was added to the tube. The solution 
was incubated for 5 minutes at 37oC to pre-heat the mix for the temperature-specific 
M-MulV reverse transcriptase (Inqaba Biotech, South Africa). The reverse 
transcriptase was then added immediately and the reaction was allowed to progress 
for 1 hour before being stopped by heating the solution to 70oC in a heating block, 
which denatured the enzyme. The resulting complementary DNA was measured for 
both concentration and purity with the use of a Nano-drop Spectrophotometer Series 
ND-100, before being stored at -20oC for further use. 
 
3.5.4 Nested Polymerase Chain reaction 
Nested PCR was performed to both optimize the primers and to identify amelogenin 
and laminin expression by amplifying the DNA of choice in the synthesized cDNA 
samples from the first mandibular molar explants. 2µl of cDNA was added to 8.5 µl 
DNase-free water to which 1µl of both forward primer 1 (amelogenin or laminin) 
and reverse primer (Table 1) was added. 12.5µl of GoTaq ® Green Master mix 
(Promega, South Africa) was included in this mix and the process was permitted to 
run for 30 cycles with a designated PCR machine program (see below) originating 
from Gibson, et al., 2001.  
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 Denaturation temperature                                      94oC                      1 minutes 
 Annealing temperature amelogenin primer          61oC                      2 minutes 
 Annealing temperature laminin primer                 59oC                      2 minutes 
 Extension temperature                                            72oC                       3 minutes 
The resulting solution was then diluted 20x in DNase-free water of which 10µl was 
added to a new 0.5ml eppendorf tube. A further 12.5 µl GoTaq ® Green Master mix 
(Promega, South Africa) was added and 1µl of forward primer 2 (amelogenin) or 1µl 
of forward primer 1 (laminin) (Table 1) and reverse primer was added. This sample 
was then amplified using the same PCR protocol.  
An aliquot of 10µl of each amplified sample was then run on a standard 1.4% 
agarose gel supplemented with 10% ethidium bromide. In order to identify the 
amplified product a molecular weight marker (Appendix 1C) was also run on the gel.   
Fragments were visualized under a Pharmacia Image-Master VDS system (BIO-
RAD, South Africa). 
 
3.5.5 PCR controls 
Two negative controls were included in each PCR run. The first was a water control 
containing forward and reverse primers but lacking the GoTaq ® Green Master mix 
(Promega, South Africa). This showed whether the water contained any DNA 
sequences that could be amplified during PCR. The second negative control 
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consisted of GoTaq ® Green Master mix (Promega, South Africa) with forward and 
reverse primers and lacking the DNase-free water. This indicated whether the 
GoTaq® Green Master mix (Promega, South Africa) was contaminated 
The amplification of the β-actin gene represented the positive control and was 
included in each PCR run to test the viability of the synthesized cDNA and to ensure 
that the DNA originated from eukaryotic tissue. 
 
3.5.6 Quantitative Real-time Polymerase Chain reaction 
Quantitative Real-time PCR was performed with only the first set of primers, since 
the ABI 7500 PCR machine was able to detect low levels of amplification. The only 
substitution in the reaction mixture was that of the master mix, which was replaced 
by iTaq SYBR-green supermix (BIO-RAD, South Africa). The latter master mix is 
specifically designed to produce a fluorescent signal after each successful 
amplification of the designated substrate. With the help of the Applied Biosystems 
Software 7500 v1.2.3 and a PCR machine from Applied Biosystems, South Africa, 
coupled to a computer, both the relative quantity of the amelogenin and laminin α5 
gene could be determined through the use of the Ct (threshold cycle) which was 
calculated by the software after each run.  The Ct value was then converted to a 
numerical value using the following formula:  
1.) ∆Ct = Ct (sample) – Ct (endogenous control) 
2.) ∆∆Ct  = ∆Ct  - Ct (Calibrator) 
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3.) 2 –∆∆Ct = relative quantity 
Where  
endogenous control = β actin   
Calibrator = Amelogenin-or laminin α5 gene expression from 6.5 day mouse pup   
In order to determine whether the gene expression was significant in control, citral-
treated and wortmannin-treated groups, a paired Students’ t-test was performed. Any t 
value ≥ t value at P = 0.05 was considered significantly different.  
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4. Results 
4.1 Morphology and histology of the mouse first mandibular molar 
Approximately 57% (n=140) of the NMRI x NMRI embryonic mouse first mandibular 
molar explants survived the 12-day culture period (Table 2), while the remaining 43% 
(n=104) degenerated or the explants keratinized. The teeth which survived the long 
culture period showed an increase in size of the molar bud, including clear 
morphodifferentiation of the molar into its typical multicuspid structure (Fig. 3).    
 
Table 2.  The percentage of molar explants in culture which survived 
 
Age in days and 
type of treatment  
Total teeth in 
culture 
Number (and 
percentage) of 
cultured molar 
explants degraded 
or keratinized after 
12 day culture 
Number (and 
percentage) of 
cultured molar 
explants with 
normal development 
after 12 day culture 
14.5 Control               42       16     (38.0%)       26     (61.9%) 
14.5 Citral                18         6     (33.3%)       12     (66.7%) 
14.5 Wortmannin               23        10    (43.5%)       13     (56.5%) 
16.5 Control                79        38    (48.1%)       41     (51.9%) 
16.5 Citral                45        18    (40.0%)       27     (60.0%) 
16.5 Wortmannin                37        16    (43.2%)       21     (56.8%) 
Total               244      104    (42.6%)     140     (57.4%)       
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Figure 3.  Representative photomicrograph of a multicuspid first and developing second 
mandibular molar after a culture period of 12 days.  
10X stereomicroscope 
 
 
Histological observations of 6.5 day mouse pup first mandibular molars  
First mandibular molars (n=2) extracted from postnatal 6.5 day old mouse pups, showed 
that the teeth were at the late bell stage of tooth development. The stellate reticulum 
between the inner and outer enamel epithelial cells layers was clearly visible and the cells 
located on the surface of the differentiated ameloblasts had condensed into a thin cell 
layer, the stratum intermedium (Fig. 4A). The ameloblasts, stellate reticulum and stratum 
intermedium were distinguishable from each other, as there was no compression between 
these cellular layers. The ameloblasts had a columnar shape and their nuclei were 
2nd 
mandibular 
molar 
1st mandibular molar 
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positioned at the basal pole of the cells (towards the stratum intermedium). Thick layers 
of enamel, dentin and predentin matrices could be observed, as well as columnar 
odontoblasts, which had differentiated from the underlying peripheral cells of the dental 
papilla (Fig. 4A). The dental follicle, a condensation of ectomesenchymal cells, 
surrounded the tooth bud. 
 
Histological observations of 14.5 day and 16.5 day in vitro control first mouse molar 
explants  
Control 14.5 day (n=26) and 16.5 day (n=41) embryonic first mouse molars, cultured for 
12 days, showed that the teeth were at the early bell stage of tooth development (Fig. 4B 
= 14.5 day control molar; Fig. 4C = 16.5 day control molar). The epithelial cells, between 
the inner and outer enamel epithelial layers, had formed the stellate reticulum (Figs. 4B, 
4C). The cells of the stellate reticulum had condensed and formed a thin stratum 
intermedium layer. The outer enamel epithelial layer, although present, was difficult to 
distinguish from the stellate reticulum or the stratum intermedium due to condensation 
between these cellular layers (not shown in Figs. 4B, C).  The inner enamel epithelial 
cells (ameloblasts) were columnar in shape and their nuclei were at the basal pole of the 
cells.  The enamel/dentin layers were absent and only a predentin layer was observed. 
The peripheral cells of the dental papilla, near the predentin layer had differentiated into 
odontoblasts (Fig. 4B), which were columnar in shape with their nuclei positioned at the 
basal pole of these cells. The cultured molar explants had a partially intact dental follicle, 
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which was found surrounding the tooth bud. There were no histological differences 
between the 14.5 day and 16.5 day control molar explants. 
 
Histological observations of 14.5 day and 16.5 day citral-treated first mouse molar 
explants  
Cultured 14.5 day (n=12) and 16.5 day (n=27) embryonic first mouse molars treated with 
citral for 5-hours, were also at the early bell stage of tooth development, following 12 
days culture in vitro. The cells of the stellate reticulum had condensed and formed the 
stratum intermedium against the ameloblast layer (Figs. 4D, E). The outer enamel 
epithelium was observed in the molar explants (not shown in Figs. 4D, E) but, due to the 
high degree of condensation of the stratum intermedium and stellate reticulum near the 
outer enamel epithelium, it was very difficult to distinguish the various cellular layers. 
The ameloblasts were columnar in shape and their nuclei were situated at the basal pole 
of the cells, i.e. away from the original basement membrane (Fig. 4D, E). Neither an 
enamel nor dentin matrix was observed. However there was a very thick predentin layer. 
The underlying peripheral cells of the dental papilla, near the predentin border, had 
differentiated into odontoblasts.  The dental follicle surrounding the tooth bud was 
present. There were no histological differences between 14.5 day and 16.5 day citral-
treated molar explants. No histological variation could be observed when the 14.5 day 
and 16.5 day citral-treated molar explants were compared with the untreated cultured 
14.5 day and 16.5 day molars. 
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Histological observations of 14.5 day and 16.5 day wortmannin-treated first mouse 
molar explants  
There was little histological difference between molar explants cultured in citral or in 
wortmannin. The cultured 14.5 day (n=13) and 16.5 day (n=21) wortmannin-treated 
embryonic mouse first molars cultured for 12 days, showed that the teeth were at the 
early bell stage of tooth development.  A stellate reticulum and stratum intermedium were 
present (Figs. 4F, G). The outer enamel epithelium was present in most of the molar 
explants but was once again condensed against the stellate reticulum. Columnar 
ameloblasts lined the undersurface of the “bell”. No enamel or dentin matrix could be 
seen, but, there was a very thick predentin layer present, as seen in the citral-treated 
explants. The dental papilla was present and the cells bordering the predentin had 
differentiated into odontoblasts. There was no histological difference between the 14.5 
day and the 16.5 day wortmannin-treated molar explants. When compared to the 14.5 day 
and 16.5 day control cultured molar explants, no deformities in either tooth cusp or tooth 
shape (not shown) or histology were observed in either the 14.5 day or the 16.5 day 
wortmannin-treated molar explants.  
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Figure 4. (A) Representative histological section of a first mandibular molar extracted from a 6.5 day mouse pup, to show 
specific cell and tissue layers of the tooth when the tooth is in the late bell stage of tooth development (63 X Light 
microscope (LM)). (B) Section from a 14.5 day embryonic first mandibular molar control explant, cultured for 12 days, 
showing the tooth at an early bell stage of tooth development. Note clear differentiation of ameloblast/odontoblast cells 
(100X LM). (C) Section of a control first mandibular molar from a 16.5 day mouse embryo, cultured for 12 days, at the 
early bell stage of tooth development (63X LM). (D) A section from a 14.5 day citral-treated embryonic mouse molar, 
cultured for 12 days, at the early bell stage of tooth development (63X LM). (E)  A section taken from a 16.5 day mouse 
citral-treated embryonic mouse molar explant, cultured for 12 days, at the early bell stage of tooth development. 
Ameloblasts and odontoblasts have differentiated (100X LM). (F) Section from a 14.5 day, 12 day cultured first 
mandibular embryonic molar explant treated with wortmannin shows that the tooth is at the early bell stage of tooth 
development since ameloblast and odontoblasts have differentiated (100X LM). (G) A section of a 16.5 day embryonic 
mouse first mandibular molar cultured for 12 days and treated with wortmannin for 5-hours (63X LM). The molar is at the 
early bell stage of tooth development. Due to the obliqueness of the section it appears that the predentin is thicker than in 
the controls  
  
 
Note: AB = ameloblasts; OB = odontoblast; E= enamel; PD= predentin; D = dentin; DP = dental papilla; 
STI = stratum intermedium; DF = dental follicle; OEE = outer enamel epithelium; N = nucleus  
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4.2 Immunocytochemistry 
4.2.1 Amelogenin localization 
6.5 day neonatal mouse molars 
Both of the 6.5 day neonatal mouse pup first mandibular molars showed a positive 
immunoreaction for amelogenin. The immunolocalization of amelogenin, in the 
mouse pup molars was situated in the ameloblasts (Fig. 5A). Furthermore, 
amelogenin was found in the odontoblasts and their odontoblastic processes, which 
were observed as dark lines within the dentin matrix. Some immunolocalization was 
also observed in the stratum intermedium. One could argue that, the 
immunolocalization in the odontoblasts, odontoblastic processes and stratum 
intermedium are due to entrapment of air, but this is negated by the negative 
control. In negative controls (adjacent sections), no immunoreaction with the 
amelogenin antibody was obtained when either the primary or secondary antibody 
were replaced with non-immune rabbit serum (not shown) or PBS (Fig. 5B) 
respectively.  However, in some instances the enamel reacted positively in the 
negative controls. This may be due to folds in the enamel between which DAB has 
become trapped and due to an over-exposure to light changed colour (Fig. 5B) 
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14.5 day and 16.5 day control molar explants  
Of the six 14.5 day and the six 16.5 day control molar explants used to test for 
immunolocalization of amelogenin, three molar explants from each age group 
reacted positively with the anti-amelogenin antibody (Table 3). The 
immunolocalization for amelogenin was localized within the secretory tip of the 
ameloblast cells, where the Tomes process is located (Fig. 5C, 5D). Substitution of 
either the primary or secondary antibody in an adjacent section with non-immune 
rabbit serum or PBS respectively, produced negative results, i.e. no immunoreaction 
occurred (Fig. 5E, 5F). The immunoreaction in Fig. 5E is a photosensitive reaction 
that occurs when DAB becomes trapped in folds of the enamel, which is brought 
about due to uneven section cutting. No difference in amelogenin 
immunolocalization was observed when 14.5 day and 16.5 day control molar 
explants when compared with each other or when compared to the 6.5 day old 
mouse pup. 
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Figure 5. (A) Representative photomicrograph of a 6.5 day neonatal mouse pup first mandibular molar in which 
amelogenin immunolocalization has occurred in ameloblasts, odontoblasts, odontoblastic processes and stratum 
intermedium (100X Differential interference contrast microscope (DIC). (B) Negative control of a 6.5 day mouse pup 
molar shows no amelogenin localization when secondary antibody is replaced with PBS. Note DAB which has become 
trapped in folds in the enamel is reacting due to an over-exposure to light and is not to be confused with 
immunolocalization (100X DIC). (C) Representative photomicrograph of a 14.5 day cultured control embryonic 
mouse molar immunolocalized for amelogenin, shows localization in the secretory pole of the ameloblast cells 
including the Tomes process located at the tip of the secretory cell surface of the ameloblasts (63X DIC). (D) 
Representative photomicrograph of a 16.5 day cultured control embryonic mouse molar, immunolocalized for 
amelogenin shows clear localization in the ameloblast cells including a thin line running along the tip of the 
ameloblasts/predentin border (63X DIC). (E) Substitution of the primary antibody with non-immune rabbit serum 
shows no localization to be present when tested in an adjacent section to the section (Fig. 5C) used for positive 
immunolocalization (63X DIC). The darkening in the section is due to the same effect described in Fig. 5B.  (F) 
Negative control section, adjacent to the section used for positive immunolocalization (Fig. 5D) in which the 
secondary antibody was substituted with PBS shows no localization for amelogenin (63X DIC). 
 
Note: AB = ameloblast; OB = odontoblast; PD = predentin; DP = dental papilla; STI = stratum intermedium; TP = 
Tomes process; AMG = amelogenin; D = dentin; E = enamel; SR = stellate reticulum. (B) is an adjacent section to 
(A); (E) is an adjacent section to (C); (F) is an adjacent section to (D)    
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Table 3. The number of explants from the various groups which reacted positively with 
the amelogenin or laminin antibody. 
 
Age and type of 
molar explant 
Number of 
explants 
used for 
ICC 
Number (and 
percentage) of 
cultured 
molar 
explants with 
amelogenin 
immuno-
localization 
Number (and 
percentage) 
of cultured 
molar 
explants 
with  no 
amelogenin 
immuno-
localization 
Number (and 
percentage) of 
cultured 
molar 
explants with 
laminin 
immuno-
localization 
Number (and 
percentage) of 
cultured 
molar 
explants with 
no laminin 
immuno-
localization 
14.5 Control         6   3 (50.0%)   3 (50.0%)   2 (33.3%)   4 (66.6%) 
14.5 Citral         6   3 (50.0%)   3 (50.0%)   2 (33.3%)   4 (66.6%) 
14.5 Wortmannin         6   2 (33.3%)   4 (66.6%)   2 (33.3%)   4 (66.6%) 
16.5 Control         6   3 (50.0%)   3 (50.0%)   4 (66.6%)   2 (33.3%) 
16.5 Citral         6   2 (33.3%)   4 (66.6%)   3 (50.0%)   3 (50.0%) 
16.5 Wortmannin         6   3 (50.0%)   3 (50.0%)   4 (66.6%)   2 (33.3%) 
Total        36 16 (44.4%) 20 (55.6%) 17 (47.2%) 19 (52.8%) 
 
 
14.5 day and 16.5 day citral-treated first molar explants  
Of the six 14.5 day and the six 16.5 day citral-treated molar explants, three 14.5 day 
and two 16.5 day molar explants showed positive immunolocalization for 
amelogenin (Table 3). The amelogenin peptide was localized in the secretory tip of 
the ameloblasts, where the Tomes process originates, as well as in some of the 
odontoblasts (Fig. 6A, 6B). Furthermore, during the sectioning of some of the 
explants an artifactual break occurred in the tissues, which led to some ameloblasts 
being separated at the ameloblast/predentin junctions. The effect of this was that 
some immunolocalization occurred on the surface of the predentin matrix, in 
fragments of the Tomes process left behind during the ameloblast separation.   
When 14.5 day and 16.5 day citral-treated molar explants were either compared to 
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each other or to the 14.5 day and 16.5 day cultured control molar explants no 
difference in amelogenin immunolocalization was observed. 
 
14.5 day and 16.5 day wortmannin-treated first molar explants  
Of the six 14.5 day and the six 16.5 day wortmannin-treated first molar explants, 
two 14.5 day and three 16.5 day molar explants showed positive 
immunolocalization for the amelogenin peptide (Table 3). The immunolocalization 
was observed in the apical tips of the odontoblasts and in the Tomes processes of the 
ameloblasts (Fig. 6C, 6D).   No difference in immunolocalization was detected 
between 14.5 and 16.5 day wortmannin-treated molar explants. In relation to the 
untreated cultured 14.5 day and 16.5 day molar explants no difference in 
immunolocalization was observed. 
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Figure 6.  (A) Representative photomicrograph of a section from a 14.5 day citral-treated first mandibular molar explant 
(63X DIC) amelogenin shows that the peptide is localized near the secretory tip of the ameloblast cells, where the Tomes 
process is located. (B) In a section from a 16.5 day citral-treated molar explant (63X DIC) immunolocalized for 
amelogenin, the protein is localized at the secretory poles of the ameloblast cells, where the Tomes process is found. (C) 
Positive immunolocalization for amelogenin was also seen in the section of a 14.5 day molar (100X DIC) and (D) 16.5 
day molar explant (63X DIC) which were treated for 5-hours with wortmannin. Amelogenin was found to be 
immunolocalized near and around the Tomes process of the ameloblast and in the secretory tips of the odontoblasts.  
 
Note: AB = Ameloblasts; OB = Odontoblasts; PD = dentin; TP = Tomes Process; DP = dental papilla; TPF = Tomes 
Process fragments 
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4.2.2. Laminin immunolocalization 
6.5 day neonatal first mouse molars 
A positive immunoreaction for the laminin antibody was observed in both of the 6.5 
day mouse pup first mandibular molars utilized. The laminin peptide was 
immunolocalized at the basal end of the ameloblasts (Fig. 7A). Interestingly the 
enamel matrix also showed immunolocalization for laminin. However, this was 
determined to be an artifactual reaction which is caused when, during sectioning of 
the tissue, folds are created in the inorganic matrix, i.e. enamel. The grooves 
produced by enamel can trap excess dye i.e. DAB, which due to its photosensitivity 
reacts over time, giving the impression that the inorganic matrix reacted. The 
negative control sections clearly showed this phenomenon. There was no 
immunolocalization in the other tissue layers of the molar when either the primary 
or secondary antibodies were replaced with non-immune rabbit serum or PBS (Fig. 
7B) respectively, except in the enamel matrix.  
 
14.5 day and 16.5 day control molar explants  
Of the six 14.5 day and the six 16.5 day control molar explants used to 
immunolocalize laminin, two 14.5 day and four 16.5 day molar explants reacted 
positively with the anti-laminin antibody (Table 3). No immunoreaction for laminin 
occurred in the secretory poles of either the ameloblasts or the odontoblasts of the 
control molar explants (Fig. 7C, 7D). However, there was immunolocalization of 
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laminin between the ameloblasts and odontoblasts, which appeared to be a residual 
basement membrane. This immunolocalization was seen in both the 14.5 day and 
16.5 day control molar explants (Fig. 7C, D). When either the primary or secondary 
antibody was substituted with non-immune rabbit serum or PBS respectively, no 
immunolocalization for laminin occurred (Fig. 7E, 7F). Compared to each other, 
14.5 and 16.5 day control molar explants showed no difference in terms of laminin 
immunolocalization. However compared to the 6.5 day mouse pup molar 
immunolocalization, 14.5 day and 16.5 day molar explants did not show laminin 
immunolocalization in the basal region of the ameloblasts. 
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Figure 7.  (A) Representative photomicrograph of a neonatal first mandibular mouse pup molar for the 
immunolocalization of laminin. (63X DIC) (B) Replacing the secondary antibody with PBS, in an adjacent section, 
showed no localization of laminin. Note that the DAB is reacting with the calcium ions in the enamel matrix which is 
not to be confused with immunolocalization (63X DIC). Therefore the localization seen in Fig. 7A in the enamel matrix 
is an artifactual reaction. (C) Representative photomicrograph of a 14.5 day cultured first mandibular control molar, 
indicating immunolocalization for laminin in the basement membrane region (63X DIC) (D) Representative 
photomicrograph of a 16.5 day cultured first mandibular control molar, shows that laminin immunolocalization 
occurred at the ameloblast/predentin junctions (63X DIC). (E) In an adjacent section in which the primary antibody was 
replaced with non-immune rabbit serum there is no immunolocalization of laminin (63X DIC) (F) Substitution of the 
secondary antibody with PBS, in an adjacent section to the one used in Fig.7D, did not produce a reaction (63X DIC) 
Note: AB = ameloblasts; OB = odontoblasts; PD = predentin; STI = stratum intermedium; BM = basement membrane; 
D = dentin; PD = dental papilla; E = enamel; SR = stellate reticulum; LAM = laminin. (B) is an adjacent section to (A); 
(E) is an adjacent section to (C); (F) is and adjacent section to (D) 
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14.5 day and 16.5 day citral-treated first molar explants  
Of the six 14.5 day and the six 16.5 day citral-treated first molar explants tested for 
laminin immunolocalization, two 14.5 day and three 16.5 day molar explants 
reacted weakly with the laminin antibody (Table 3). Once again, the 
immunolocalization for laminin was observed between the ameloblast layer and the 
predentin and was found either near the cusps of the 14.5 day citral-treated molar 
explants (Fig. 8A) or near the cervical loop of the 16.5 day citral-treated molar 
explants (Fig. 8B). Neither the ameloblasts nor the odontoblasts showed any 
immunolocalization for laminin. When compared to the 14.5 day and 16.5 day 
control molar explants, no difference in laminin immunolocalization was observed 
in those explants treated with citral. 
 
14.5 day and 16.5 day wortmannin-treated molar explants  
Of the six 14.5 day and the six 16.5 day wortmannin-treated molar explants, two 
14.5 day and four 16.5 day molars showed positive immunoreactivity with the 
laminin antibody (Table 3). In the 14.5 day wortmannin-treated molars (Fig. 8C, 
circled area) there was weak immunolocalization, in the region where the basement 
membrane is normally situated. The odontoblasts did not show any localization for 
laminin. In the 16.5 day wortmannin-treated molars (Fig. 8D) immunolocalization 
was predominantly observed in the apical tips of the ameloblasts. It would seem that 
laminin localization was also found in the stratum intermedium but this 
immunolocalization occurred because stellate reticulum and stratum intermedium 
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were highly condensed.  When comparing the 14.5 day and 16.5 day wortmannin-
treated molars to the 14.5 day and 16.5 day untreated molar explants, the main 
difference was that the wortmannin-treated explants showed laminin 
immunolocalization in the apical tips of the ameloblasts but lacked the laminin 
localization between the ameloblasts and odontoblasts cell layers. 
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Figure 8.  (A) Representative photomicrograph of a 14.5 day citral-treated first mandibular molar explant section, 
showed immunolocalization at the tip of the cusp of the molar, between the ameloblasts and predentin (X63 DIC). 
(B) Representative photomicrograph of a 16.5 day citral-treated first mandibular molar explant section showed 
immunolocalization of laminin to be present only in the basement membrane near the cervical region of the root of 
the tooth (X63 DIC). (C) A section of a 14.5 day molar explant which was treated for 5-hour s with wortmannin, 
showed immunolocalization of laminin  in the basal tip of the ameloblast (X63 DIC). (D) In the section of a 16.5 day 
wortmannin-treated first mandibular molar explant laminin immunolocalization was observed in the secretory tip of 
the ameloblasts (X100 DIC). Note that the condensed STI and SR is an artifactual immunolocalization of laminin. 
 
Note: AB = Ameloblasts; OB = odontoblasts; PD = predentin; DP = dental papilla; BM = basement 
membrane; CV = cervical loop; STI = stratum intermedium; LAM = laminin, SR = stellate reticulum 
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4.3 Gene expression 
4.3.1 Amelogenin expression 
The amelogenin gene was initially identified in a 6.5 day mouse pup first 
mandibular molar through the use of total mRNA extraction and DNA amplification 
by nested-PCR. The resultant ~200bp gene (Fig. 9) was then extracted and purified 
from a 1% agarose gel and sent for sequencing by Inqaba Biotech Laboratories. 
Since the ~200bp gene was detected in conjunction with primer dimer formation 
(Fig. 9) and other possible DNA contamination, it was necessary to do sequencing 
in order to confirm that this nucleotide fragment constituted part of the mouse 
amelogenin gene. A nucleotide-based search, BLASTn, (www.pubmed.com) 
illustrated that the extracted DNA band aligned perfectly with a section of the 
original amelogenin gene (Fig. 10) from which the primers were designed. The 
partial amelogenin mRNA transcript was found to be amplified and was expressed 
in all cultured molar explants that included 14.5 day (n=6) and 16.5 day (n=6) 
control explants as well as the samples treated with citral- (n=6 [14.5 day]; n=6 
[16.5 day]) and wortmannin- (n=6 [14.5 day]; n=6 [16.5 day]).  
 
4.3.2 Laminin α5 expression 
The laminin α5 gene was originally identified in a 6.5 day mouse pup first 
mandibular molar by total mRNA extraction and amplification from the resultant 
cDNA with the use of nested-PCR. A ~215bp primer was designed from the known 
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nucleotide sequence of the mouse laminin α5 gene. The amplification of this DNA 
band via nested-PCR was observed on a 1% agarose gel (Fig. 11). Since the 
nucleotide fragment was detected at the correct size without the presence of primer 
dimers and any other contamination, no sequencing was necessary in this case. With 
the aid of this data, the laminin α5 partial primer sequence was found to be 
amplified and expressed in all 14.5 day (n=6) and 16.5 day (n=6) control murine 
molar explants, together with those treated for 5-hour s with citral (n=6 [14.5 day]; 
n=6 [16.5 day]) or wortmannin (n=6 [14.5 day]; n=6 [16.5 day]).  
 
4.4. Quantitative Real-time Polymerase Chain Reaction 
4.4.1 QRT-PCR Amelogenin 
QRT-PCR analysis was performed to compare the difference in amelogenin gene 
expression between the 14.5 day and 16.5 day embryonic control first molar explants 
with those of the 14.5 day and 16.5 day citral- or wortmannin-treated first molar 
explants (Fig. 12).  
The analysis revealed that there was no significant change (P≤ 0.05) in amelogenin 
expression between the 14.5 day and 16.5 day control molar explants (Fig. 12). When 
the amelogenin expression of the 14.5 day control molars and the 14.5 day citral-
treated molars was compared, amelogenin gene expression of the 14.5 day citral-
treated molars had significantly increased (P>0.05; Appendix C) with regard to that 
of the 14.5 day control and the 16.5 day citral-treated molar explants (Fig 12). 
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However statistical analysis revealed that the amelogenin expression in the 16.5 day 
citral-treated molar explants was not significantly different from that of the 16.5 day 
control molar explants (P<0.05). When the 16.5 day molar explants treated with 
wortmannin were compared to the 16.5 day control molars, amelogenin gene 
expression was also not significantly different (P<0.05; Appendix E). Furthermore, 
there was no significant difference (P<0.05) in amelogenin-mRNA synthesis between 
the 14.5 day wortmannin-treated molar explants and the 14.5 day control molar 
explants (Fig.12).  When comparing the 14.5 day wortmannin-treated explants with 
the 16.5 day wortmannin-treated explants, no significant difference (P<0.05) in 
amelogenin-mRNA levels were detected. 
 
4.4.2 QRT-PCR Laminin α5 
QRT-PCR was performed in order to assess the expression of the laminin α5 gene in 
control explants of 14.5 day and 16.5 day explants cultured for 12 days, with their 
corresponding citral- or wortmannin-treated first molar explants.  The difference in 
laminin α5 expression between the 14.5 day and 16.5 day control first molars was 
statistically insignificant (Appendix E) (Fig. 13).  
 
The 14.5 day citral-treated embryonic mouse first molars showed no significant 
difference (P>0.05; Appendix E) in laminin α5 gene expression compared to the 14.5 
day control first molars. The laminin α5 gene expression in the 16.5 day citral-treated 
 - 63 -
first molar explants was also not significantly different (P<0.05) when compared to 
the 16.5 day control first molar explants. When comparing 14.5 day citral-treated 
molars to their 16.5 day citral-treated counterparts, the statistics revealed that they 
were not significantly different (P<0.05).  When 14.5 day wortmannin-treated first 
molars and 14.5 day control first molars were compared, again there was no 
significant difference (P>0.05) in laminin α5 expression to that of the control first 
molar explants (Fig. 13). A significant difference (P>0.05) in laminin α5 gene 
expression between the 16.5 day wortmannin-treated first molars and the 16.5 day 
control first molar explants was not detected. Neither was a significant difference 
found when the 16.5 day wortmannin-treated explants were compared with the 14.5 
day wortmannin-treated first molars. 
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Figure 9. Amelogenin gene expression using nested-PCR. 
Lane 1: β-actin housekeeping gene 
Lane 2: DNA Ladder, Low Range 
Lane 3-6: Different dilutions of cDNA starting product amplified for amelogenin 
 
 
 
 
 
 
 
 
 
 
 
     
Figure 10.  BLASTn sequence alignment analysis indicating that the extracted DNA band is the 
amelogenin sequence initially selected to be amplified by the primers. Note: The sequence is 
slightly shorter than expected which is caused by the loss of nucleotides during the sequencing 
process. 
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Figure 11. Laminin α5 gene expression using nested-PCR.  
Lane 2: β-actin housekeeping gene 
Lane 3: DNA Ladder, Low Range 
Lane 4-5: cDNA from 6.5 day neonatal mouse pup first mandibular molars amplified for 
laminin α5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
       Figure 12. Graphical representation of the relative amelogenin gene expression of 14.5 day 
and 16.5 day first mandibular molars. Explants were cultured as controls or treated with citral 
for 5-hour s or were exposed to wortmannin for 5-hour s. 
*, * = Significantly different   Note: The same coloured stars on top of two groups e.g. control and 
citral denotes that they are significantly different from each other. 
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Figure 13. Graphical representation of the relative laminin gene expression of 14.5 day and 
16.5 day embryonic first mandibular molars. Explants were either grown as controls, 
treated with citral or were exposed to wortmannin. 
Note: None are significantly different 
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5. Discussion  
 
 
5.1 Approaches to regulating enamel thickness and enamel patterning (cusp 
morphology) 
 
The current work explored the different ways in which enamel thickness and cusp 
morphology of the first mandibular molars of embryonic mice could be regulated or 
perturbed, as this may bear on the adaptation of teeth during the course of evolution. Two 
reactions bear on enamel and cusp formation, namely amelogenin in relation to enamel 
formation, and laminin which regulates differentiation of ameloblasts and odontoblasts. 
To perturb these reactions two inhibitors were used namely citral, which inhibits RA 
synthesis, and wortmannin, which prevents PI3K activation resulting in inhibition of 
laminin production. These steps are depicted in figure 14.  
 
 
 
 
 
 
 
 
 
 
Figure 14. Reaction sequence depicting the effect of retinoic acid (RA) on gene expression of amelogenin 
and laminin. In normal development RA is lowered on embryonic day 16.5 (Niederreither et al., 2002) 
which is correlated with the downregulation of Notch and an increase in amelogenin-mRNA. Citral can 
inhibit retinaldehyde dehydrogenase, which should lead to decreased RA concentrations before embryonic 
day 16.5 (Kronmiller et al., 1995a). Subsequently RA regulates PI3K activation by PDGF (Pedigo et al., 
2007) which modulates laminin gene expression. Laminin controls the differentiation of ameloblasts and 
odontoblasts which in turn regulate tooth patterning and cusp morphology (Eltit and Oyarzin, 2007) 
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Couwenhoven and Snead (1994) showed that whereas RA is high at the bud stage and 
low after the bell stage of tooth development, amelogenin is low at the bud to cap stage 
but higher after the bell stage (Fig. 15). Would a premature lowering of the level of RA 
lead to a premature burst of amelogenin synthesis, as reflected in terms of amelogenin 
mRNA levels and a changed morphology? 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 
                         
                          Bud stage   Cap stage         Bell stage 
 
 
 
 
 
 
 
Figure 15. Diagrammatic representation which shows that, under normal growth conditions, when retinoic 
acid (RA) decreases at embryonic day 16.5 amelogenin levels increase (Couwenhoven and Snead, 1994; 
Niederreither et al., 2002).  
           Niederreither et al., 2002             Couwenhoven and Snead, 1994 
            
In the first part of the discussion the effect of citral and wortmannin treatments on the 
morphology and histology of embryonic first mandibular molars in mice will be 
addressed. In the second part the level of mRNA which promotes amelogenin-mRNA and 
laminin-mRNA synthesis will be addressed. 
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5.1.1 In vitro development of embryonic mouse molars and the effects of citral and 
wortmannin on the morphology, histology and protein synthesis  
 
The results from the present study revealed that teeth cultured in vitro for 12 days did not 
develop to the late bell stage of tooth development. Treated and controls control molar 
explants from the 14.5 and 16.5 day groups had only reached the mid-bell stage, when 
compared to the normal in vivo development of the first mandibular molar from a 6.5 day 
mouse pup. Morphologically, the teeth appeared to be smaller than the in vivo first molar 
but possessed a normal multicusped shape. However the formation of enamel was absent 
in the cultured teeth, even though immunocytochemically amelogenin synthesis was 
detected in the 14.5 and 16.5 day control and citral-and wortmannin-treated molar 
explants. Immunocytochemistry for laminin in the 14.5 and 16.5 control or citral-treated 
first molar explants was detected in ameloblasts and odontoblasts including at the 
junction of the ameloblast and predentin layer, which suggests that the basement 
membrane was still in the process of being degraded. This led to the hypothesis that all 
cultured teeth, upon extraction from their in vivo environment experienced a very slow 
rate of development, which resulted in the cultured first mandibular molars reaching the 
mid-bell stage of tooth development, which is characterized by ameloblast/odontoblast 
differentiation, the start of amelogenesis, the presence of an intact basement membrane 
and the presence of a pre-dentin layer but no enamel matrix.  
Hay (1961) in her research on the development of in vitro and in vivo mouse incisors and 
molars showed that molars of mice cultured in vitro experienced a very slow rate of 
development. Under normal in vivo conditions teeth cultured from either the cap stage 
(E14.5) or early bell stage (E16.5) for 12 days reached approximately the 6th day of post-
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natal development. Histologically, the cells of the various tissue layers of the molar, such 
as the inner enamel epithelium and the outer enamel epithelium would have differentiated 
by embryonic day 16 to 17 into their specific cell types i.e. ameloblasts and odontoblasts 
respectively, with nuclei migrating away from these cells’ apical pole. The stratum 
intermedium would have formed deep to the ameloblasts to assist with controlling enamel 
production (Cohn, 1957; Hay, 1961). Thick extracellular matrices such as predentin, 
dentin and enamel would have been formed by postnatal day 6 (Hay, 1961), as was seen 
in the 6.5 day pup in the present study. The process of amelogenesis would have reached 
the mature stage of development, i.e. amelogenin content of enamel is being replaced by 
hydroxyappatite crystals and calcium/phosphate ions (Hay, 1961). The results of Hay 
(1961) indicated that the developing mouse teeth when cultured in vitro, irrespective at 
what stage of tooth development they were extracted at, developed only for a certain 
period, i.e. cap stage to bell stage, before they ceased all development. Hay (1961) 
suggests that it is a matter of culture technique utilized and that during extraction the 
tooth can become damaged, which may affect the rate of tooth development. On the other 
hand, Black (1999) suggests that the variation in diffusion distance of cells in a tissue in 
vitro, could lead to decreased developmental rates of cells or tissues located near the 
centre of the organ. If the central cells of the developing embryonic molar, such as 
ameloblasts, odontoblasts and those cells of the stellate reticulum/stratum intermedium, 
did not receive adequate nutrients to replicate, then it could explain why there was a 
slowing down in development. However, Black’s (1999) suggestion may not be related to 
the current experiment, because if this had been the case, then ameloblasts would not 
have been able to produce amelogenin. Therefore it is suggested that it is most likely due 
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to the extraction procedure and the time taken to transfer the explants into an 
environment, which caused molar explants to develop slowly in the current experiment. 
When interpreting the results of the effects of citral and wortmannin on the development 
of the first molar. results showed that these treatments did not affect the histology, 
morphology or protein synthesis of these explants. Laminin was detected in both the 
ameloblast and odontoblast cell layers, in both 14.5 and 16.5 day molar explants (control 
and treated), indicating that neither citral nor wortmannin had an inhibitory effect. 
Fukumoto et al. (2005) found that cusps of molars were “welded” together or that the tips 
of the cusps were flat following wortmannin treatment. However following wortmannin 
treatment in the present study the cusps were spaced out normally and were pointy. These 
results therefore suggest that the exposure period of 5 hours compared to the 24 hours 
used by Fukumoto et al. (2005) was possibly inadequate to affect cusp morphology and 
the synthesis of proteins such as laminin and amelogenin. Both Kronmiller et al. (1995a) 
and Fukumoto et al. (2005) in their tissue culture experiments on tooth development 
treated the teeth at the bud stage and/or cap stage with either citral or wortmannin 
respectively, for 24 hours, to produce changes in tooth development and the shape of the 
cusps. It is therefore feasible to repeat the current experiment utilizing different exposure 
periods set above the 5 hour mark and see whether this causes any changes in cusp 
morphology 
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5.1.2 The effect of citral and wortmannin on amelogenin-mRNA synthesis during 
molar development 
The results of the current experiment show that there is an early onset of amelogenin-
mRNA synthesis following citral treatment. This early onset of amelogenin-mRNA 
occurs in embryos treated at stage 14.5 which is well before the normal onset of 
amelogenesis at day 16.5 of tooth development (Zeichner-David et al., 1995). However, 
in embryonic mouse molars treated at day 16.5, a stimulatory effect of citral on the level 
of amelogenin-mRNA was not observed. The interpretation of this finding is in 
accordance with published data by Mitsiadis et al. (1995), Coffman et al. (1993) and 
Kronmiller et al. (1995a) who suggested that a lowering of the RA concentration 
correlates with the initiation of amelogenesis during tooth development. The pathway 
involved in amelogenin synthesis is depicted in figure 14 where it is seen that the 
conversion of retinol to retinoic acid may be inhibited by citral, thereby causing a pre-
amelogenin-mRNA synthesis, i.e. before day 16.5 the time of normal amelogenesis (Fig. 
15). This early onset of increased amelogenin-mRNA levels may be interpreted in terms 
of two possible feedback circuits that could control the levels of amelogenin-mRNA (Fig. 
16). In this regard it is suggested that while citral treatment at day 14.5 of development 
causes a pulse in amelogenin-mRNA in day 14.5 treated explants, there is a lag before 
amelogenin-protein accumulates to its normal level (at day 16.5). 
In the normal situation, it is suggested that the level of amelogenin-mRNA is regulated 
by the equilibrium between its synthesis and breakdown. In day 16.5 treated embryonic 
molars, synthesis and breakdown are in equilibrium. However, it is here suggested that 
while in 14.5 day embryonic molars treated with citral there is an early onset of 
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amelogenin-mRNA, the degradative mechanisms that regulate its level are not yet 
operative. 
 
 
 
 
 
 
 
Figure 16. Two feedback systems that could control the level of amelogenin-mRNA. The first is 
amelogenin protein feeding back negatively to inhibit mRNA production where the second causes 
the activation of RNase to degrade excess mRNA levels. 
 
One can postulate two types of mechanisms that maintain the level of mRNA over and 
above the particular molecular structure of amelogenin-mRNA which may also contribute 
to the stability. Firstly the negative feedback effect of amelogenin on its synthesis, and 
secondly the activation effect of amelogenin on promoting RNase activity (Fig. 16). Thus 
in the presence of too much amelogenin, the latter could act as a feedback inhibitor 
whereby it binds to elements in the synthesis pathway. However it could also be possible 
that too much amelogenin-mRNA could feedback and activate RNase. The regulation of 
mRNA levels is dependant on the structure of mRNA in terms of the G-C (guanine-
cytosine) content (Ativater et al., 1990) and the presence or absence of long poly (A) tails 
at the 3’-end (Valencia-Sanchez et al., 2006). Factors such as RNA interference 
molecules (RNAi) may also have an effect on mRNA levels, but nothing is known about 
Amelogenin- mRNA Amelogenin 
Notch 
 
RA 
Negative feedback 
RNase (Positive feedback) 
synthesis 
activate 
(E14.5) (E16.5) 
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this at present.  Thus, if amelogenin mRNA is synthesized ahead of the stage at which the 
mechanisms that control its concentration are operational, its concentration may go 
unchecked and tend to overshoot its appropriate level. That the level of amelogenin-
mRNA may be under strict control opens up the possibility of modulating amelogenin-
mRNA in normal tooth development and consequently in enamel thickness all of which 
bears on the regulatory mechanisms upon which natural secretion may act in the shaping 
of tooth morphology. 
In terms of the wortmannin inhibition of PI3K, results from the current work showed that 
the amelogenin-mRNA levels were not affected when PI3K activation was inhibited by 
wortmannin. The PI3K pathway (Fig.17) is primarily involved in regulating laminin-
mRNA via protein kinase B/Akt (Li et al., 2001). There is no indication in the literature 
that PI3K regulates amelogenin. Since no changes in cusp formation were observed in the 
present study and there was no change in amelogenin-mRNA levels it can be suggested 
that the exposure period of 5 hours to wortmannin was not long enough to induce any 
effective change in either morphology or at a genetic level. However, because a sample 
size of 6 molars was used to compile the data, it cannot be excluded that the number of 
molars used in the current experiment was too small and thus no significant difference 
could be detected when analyzed. On the other hand changes in cusp morphology do not 
appear to be related to events involved in the amelogenin-mRNA synthesis pathway, 
even though wortmannin is presumed to affect enamel patterning and cusp morphology. 
Therefore, it may be profitable to revisit these finding using a larger sample size and to 
see whether longer exposure periods yield different results.  
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Figure 17. Reaction sequence depicting the control of laminin gene expression by 
phosphoinositol-3-kinase (PI3K). Under normal conditions platelet derived growth factor (PDGF) 
is upregulated by retinoic acid (RA) (Pedigo et al., 2007), which binds with receptors that have 
the inactive PI3K component. Once released from the receptor PI3K phosphorylates PI (4, 5)P2  
to its active form PI (3,4,5)P2 (Cantley, 2002). The PI (3,4,5)P2 then activates protein dependant 
kinase 1 (PDK1) by phosphorylation which in turn phosphorylates protein kinase B (PKB)/Akt 
(Cantley, 2002). The Akt activates the NFKB pathway which then upregulates laminin-mRNA 
production (Li et al., 2001). Wortmannin inhibits PI3K activation and subsequently laminin gene 
expression. 
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5.1.3 The effect of wortmannin and citral on the levels of laminin α5-mRNA 
 
The findings of the present study did not show any variation in laminin α5-mRNA 
synthesis when either PI3K or RA were inhibited with wortmannin or citral respectively. 
Although it was thought that a loss in either PI3K or RA could have an effect on laminin-
mRNA synthesis (Fig. 17) in molar explants treated with citral at day 14.5 of 
development, a statistical analysis of the results showed that citral had no significant 
effect on laminin-mRNA synthesis. Laminins are a diverse group of proteins which are 
secreted from cells to form specialized cellular derivatives, such as the basement 
membrane which helps to regulate cellular processes. This has been especially shown in 
tooth development in which the laminins, especially laminin α5 in the basement 
membrane, are suggested to regulate the differentiation of ameloblasts of the inner 
enamel epithelium and odontoblasts of the dental papilla (Eltit and Oyarzin, 2007). It is 
therefore strange that wortmannin and citral, which inhibit PI3K activation and RA 
synthesis respectively, did not cause a change in laminin-mRNA levels.  This suggests 
one of four possibilities:  (1) These inhibitors did not effectively target the PI3K and RA 
sites in these experiments. (2) The sample size of six molars treated with either citral or 
wortmannin on which qRT-PCR was performed was inadequate to show a change in gene 
expression when citral or wortmannin were applied to first mandibular molar explants. 
(3) Variation in qRT-PCR Ct values, could suggest that laminin-mRNA was a direct 
result from different rates of synthesis in the embryonic molars or from the well known 
instability of mRNA during its extraction. (4) There are possibly other pathways which 
operate parallel to the PI3K pathway, or by cross-talk, which function to maintain the 
appropriate level of laminin α5-mRNA. It would therefore be appropriate in future 
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experiments to monitor the level of Akt and other PI3K pathway proteins to see how 
these other PI3K pathway proteins alter their activity status when PI3K or RA syntheses 
are altered.  
 
 
 
6. Conclusion  
Citral and wortmannin had no effect on the morphology, histology and 
immunolocalization of amelogenin or laminin of 14.5 day and 16.5 day first mandibular 
molars, in an in vitro system. However, the current study did provide evidence that a loss 
in RA, via citral inhibition, before the onset of amelogenesis at day 16.5 can lead to an 
early increase in amelogenin-mRNA levels. Once amelogenesis occurs and RA 
decreases, feedback and degradative mRNA systems become operational, which possibly 
regulate the synthesis of amelogenin-mRNA levels. PI3K does not seem to be involved in 
regulating amelogenin expression. As for laminin α5-mRNA, the study is uncertain on 
whether PI3K or RA may be involved in regulating this gene’s expression.   
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8. Appendices 
Appendix A 
1. Solutions for tissue extraction 
Calcium and magnesium-free Tyrode’s solution (1000ml) made up of three 
solutions 
Solution 1  
500ml dH2O 
2.0g NaCl 
0.05g KCl 
0.012g NaH2PO4H2O 
Solution 2  
480ml dH2O 
0.025g NaHCO3 
Solution 3 
20ml dH2O  
1g C6H12O6 
 
Saline solution 
1M NaCl 
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2. Solutions for tissue fixation and staining 
Formic citric acid (decalcification solution) 
1% CH2O2 
10% Na3C6H5O7.2H2O 
Adjusted to pH 5 with 5M HCL 
 
10% buffered formalin (fixative) 
4% HCHO 
3.5g NaH2PO4.H2O 
6.5g Na2HPO4 
 
Hematoxylin 
2g C16H14O6 
0.2g INaO3 
17.6g Al2O12S3 
250g C2H6O2 
730ml dH2O 
Filter before use 
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Eosin 
2.5g Sodium Tetrabromofluorscein 
500ml dH2O 
5M HCL 
Dissolve the Eosin (Sodium Tetrabromofluorscein) in the water and slowly add the 
hydrochloric acid which combines with the sodium. The resulting precipitate is the 
acid form of tetrabromofluoroscein which is insoluble in water. Allow the precipitate 
to settle, and decant the supernatant fluid. Add about 500 ml of distilled water to the 
precipitate and stir until the dye is well suspended, then allow to settle. Repeat the 
washing process about six times to remove all the traces of sodium and chloride ions. 
Filter and allow the filter paper and dye to dry in a drying oven (60°). Remove the dye 
from the paper and pulverize it in a mortar. Weigh the pulverized dye and dissolve it in 
the proportion of 100 ml of 95% alcohol for each 0.5 g of dye 
 
3. Solutions for Immunocytochemistry 
PBS 
0.58g NaCl 
1.42g Na2HPO4 
1.20g Na2H2PO4.2H2O 
950ml dH2O 
Adjust to pH 7.1 
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EDTA (antigen retrieval) 
0.37g C10H16N2O8  
1000ml dH2O 
Adjust to pH 8.0 
 
Tris-saline 
0.95% NaCl 
0.05M Tris/HCl  (pH 7.6) 
 
Diluent for antisera 
100ml Tris-saline 
0.005g bovine serum albumin 
0.04g C10H16N2O8 
1ml swine serum 
 
D.A.B. (3-3 Diaminobenzideinetetrahydrochloride) 
2ml Tris/HCl  (pH 7.6) 
1% H2O2 
Filter before use. 
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4. Storage buffers for primers 
TE 
10mM Tris/HCl (pH 8.0) 
10mM EDTA (pH 8.0) 
 
5. Buffers and solutions for Agarose Gel Electrophoresis 
5X TBE 
0.89M Tris 
0.089M Boric Acid 
0.002M EDTA 
Adjust to pH 7.6 
 
Agarose gels 
2g (1%) or 2.8g (1.4%) Agarose 
180ml dH2O 
20ml 5X TBE (pH 7.6) 
 
Running Buffer 
180ml dH2O 
20ml 5X TBE (pH 7.6) 
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Loading Buffer (Tracking dye) 
30% Glycerol in TE 
0.025% Bromophenol blue 
 
10X Loading dye 
0.25% Bromophenol blue 
0.25% Xylene cyanol 
50% Glycerol 
0.25mM EDTA 
 
6. Miscellaneous Stock  
Antibiotic Stock 
Streptomycin/ Penicillin                        100mg/ml dissolved in dH2O 
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Appendix B  
DNA molecular weight markers used in this work 
 
 
 
 
 
 
 
 
Figure 1B. FastRuler DNA Ladder. Note: Range (in bp): 1500, 850, 400, 200, 50. 
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Appendix C 
Statistical formula 
Paired t-test (Allan, 1982) 
t= mx – my/ SEDmx – my        and       mx – my = positive value 
Where mx = mean of first sample group  
my = mean of second sample group 
SEDmx – my = standard error between means 
And t has (nx + ny -2) degrees of freedom 
Where n = total number of samples compared to each other from each group 
SEDmx – my = √ [ ((sdx)2/nx) + ((sdy)2/ny)] 
Where sd = standard deviation of sample 
sdx = √ [(∑x2 – (∑x)2/n)/n-1] 
Where n = total number of samples compared 
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Appendix D 
Raw data of QRT-PCR run 
1. 2-∆∆Ct 
 
values for amelogenin expression 
Type of tooth treatment, 
age and gene expression 
analyzed 
2 -∆∆Ct after QRT-PCR 
Control 1 14.5 
amelogenin 
921.60 
C2 59.76 
C3 21424.89 
C4 62.90 
C5 222.40 
C6 3326.98 
 Mean = 4336.42 
  
Control 1 16.5 
amelogenin 
114.80 
C2 8761.73 
C3 29.91 
C4 56.77 
C5 6080.61 
C6 12819.03 
 Mean = 4643.81 
  
Citral 1 14.5 
amelogenin 
33970.62 
Ci2 45292.98 
Ci3 576.43 
Ci4 14.75 
Ci5 33947.10 
Ci6 47544.80 
 Mean = 26891.10 
  
Citral 1 16.5 
amelogenin 
880.40 
Ci2 23170.50 
Ci3 10535.71 
Ci4 4.94 
Ci5 697.47 
Ci6 2626.63 
 Mean = 6400.76 
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Wortmannin 1 14.5 
amelogenin 
9809.75 
W2 147.34 
W3 16169.64 
W4 917.14 
W5 5.30 
W6 20.99 
 Mean = 4511.70 
  
Wortmannin 1 16.5 
amelogenin 
199.33 
W2 177.05 
W3 946.86 
W4 82.48 
W5 56.45 
W6 519.87 
 Mean = 320.93 
 
 
2. 2-∆∆Ct 
 
values for laminin α5 expression 
Type of tooth 
treatment, age and 
gene expression 
analyzed 
2 -∆∆Ct after QRT-PCR  
Control 1 14.5 laminin 
α5 
188.97 
C2 772941.66 
C3 117.30 
C4 1666.96 
C5 138.43 
C6 7281.40 
 Mean = 130139.12 
  
Control 1 16.5 laminin 
α5 
0.89 
C2 87864.94 
C3 3499.66 
C4 43.23 
C5 3970.21 
C6 464719.29 
 Mean = 93349.70 
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Citral 1 14.5 laminin 
α5 
23854.93 
Ci2 10.26 
Ci3 193.47 
Ci4 3.71 
Ci5 29634.70 
Ci6 6347.62 
 Mean = 10007.45 
  
Citral 1 16.5 laminin 
α5 
9809.75 
Ci2 620469.20 
Ci3 376.90 
Ci4 92361.25 
Ci5 424.02 
Ci6 65536.0 
 Mean = 131496.19 
  
Wortmannin 1 14.5 
laminin α5 
43.77 
W2 205674.01 
W3 721.10 
W4 656301.86 
W5 1.61 
W6 221.78 
 Mean = 143827.36 
  
Wortmannin 1 16.5 
laminin α5 
277860.26 
W2 46405.24 
W3 232.50 
W4 12.27 
W5 28036.14 
W6 142.62 
 Mean = 58781.51 
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Appendix E 
Raw data and statistical calculations of the QRT-PCR runs 
1. t-test analysis (amelogenin expression) 
Six samples were used for each group (e.g. Control 1 14.5 -Control 6 14.5).  
:. nx = 6 and ny = 6 
:. Degrees of freedom = (nx + ny -2) = 6 + 6-2 = 10 
:. t (P=0.05) = 2.23 
:. Any calculated t values from two groups > 2.23 is deemed as significantly different    
a.) Control 14.5 and Control 16.5  
Control 14.5 (x) Control 16.5 (y) (x)2 (y)2 
921.60 114.80 849346.56 13179.04 
59.76 8761.73 3571.26 76767912.59 
21424.89 29.91 459025911.5 894.61 
62.90 56.77 3956.41 3222.83 
222.40 6080.61 49461.76 3697381.97 
3326.98 12819.03 11068795.92 164327530.1 
∑x = 26018.53 ∑y = 27862.85 ∑x2 = 471001043.4 ∑y2 = 278086557.1 
Mean = 4336.42 Mean = 4643.81   
 
mx – my = 4643.81 – 4336.42 = 307.39 
sdx = √ [(471001043.1 – 112827317)/5] = 8463.73 
sdy = √ [(278086557.1 – 129389735)/5] = 5453.38 
:. SEDmx – my = √ [(8463.73)2/6 + (5453.38)2/6] = 4110.4 
:. t = 307.39/4110.4 
:. t = 0.07  
:. Control 14.5 and Control 16.5 are not significantly different 
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b.) Citral 14.5 and Citral 16.5  
Citral 14.5 (x) Citral 16.5 (y) (x)2 (y)2 
33970.62 880.40 1154003023 775104.16 
45292.98 23170.50 2051454037 536872070.3 
576.43 10535.71 332271.54 111001185.2 
14.75 4.94 217.56 24.40 
33947.10 697.47 1152405598 486464.40 
47544.80 2626.63 2260508007 6899185.16 
∑x = 161346.63 ∑y = 38404.71 ∑x2= 6618703154 ∑y2 = 656034033.6 
Mean = 26891.10 Mean = 6400.76   
 
mx – my = 26891.10 – 6400.76 = 20490.34 
sdx = √ [(6618703154 – 4338789169)/5] = 21353.75 
sdy = √ [(656034033.6 – 245820291.7)/5] = 9057.91 
:. SEDmx – my = √ [(21353.75)2/6 + (9057.911)2/6] = 9469.47 
:. t = 20490.34/9469.47 
:. t = 2.20  
:. There is a marginally significant difference between Citral 14.5 and 
Citral 16 1/2  
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c.) Wortmannin 14.5 and Wortmannin 16.5  
Wortmannin 14.5 
(x) 
Wortmannin 16.5 
(y) 
(x)2 (y)2 
9809.75 199.33 96231195.06 39732.45 
147.34 177.05 21709.08 31346.70 
16169.64 946.86 261457257.7 896543.86 
917.14 82.48 841145.80 6802.95 
5.30 56.45 28.09 3186.60 
20.99 519.87 440.58 270264.82 
∑x = 27070.16 ∑y = 1925.56 ∑x2 = 358551776.3 ∑y2 = 1247877.38 
Mean = 4511.70 Mean = 320.93   
 
mx – my = 4511.70 – 320.93 = 4190.77 
sdx = √ [(358551776.3 – 122132260.4)/5] = 6876.33 
sdy = √ [(1247877.38 – 617963.55)/5] = 354.94 
:. SEDmx – my = √ [(6876.33)2/6 + (354.94)2/6] = 2810.99  
:. t = 4190.77/2810.99 
:. t = 1.49 
:. No statistical significant difference between Wortmannin 14.5 and 
Wortmannin 16.5  
 
 
 
 
 
 
 
 - 96 -
d.) Control 14.5 and Citral 14.5  
Control 14.5 (x) Citral 14.5 (y) (x)2 (y2) 
921.60 33970.62 849346.56 1154003023 
59.76 45292.98 3571.26 2051454037 
21424.89 576.43 459025911.5 332271.54 
62.90 14.75 3956.41 217.56 
222.40 33947.10 49461.76 1152405598 
3326.98 47544.80 11068795.92 2260508007 
∑x = 26018.53 ∑y = 161346.63 ∑x2 = 471001043.4 ∑y2= 6618703154 
Mean = 4336.42 Mean = 26891.10  1154003023 
 
mx – my = 4336.42 – 26891.10 = 22554.68 
sdx = √ [(471001043.4 – 112827317.2)/5] = 8463.73 
sdy = √ [(6618703154 - 4338789169)/5] = 21353.75 
:. SEDmx – my = √ [(8463.73)2/6 + (21353.75)2/6] = 9377.43 
:. t = 22554.68/9377.43 
:. t = 2.41 
:. There is a marginally significant difference in amelogenin expression 
between the 14.5 day Control and 14.5 day Citral treated molras 
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e.) Control 14.5 and Wortmannin 14.5  
Control 14.5 (x) Wortmannin 14.5 
(y) 
(x)2 (y)2 
921.60 9809.75 849346.56 96231195.06 
59.76 147.34 3571.26 21709.08 
21424.89 16169.64 459025911.5 261457257.7 
62.90 917.14 3956.41 841145.80 
222.40 5.30 49461.76 28.09 
3326.98 20.99 11068795.92 440.58 
∑x = 26018.53 ∑y = 27070.16 ∑x2 = 471001043.4 ∑y2 = 358551776.3 
Mean = 4336.42 Mean = 4511.70   
 
mx – my = 175.28 
sdx = √ [(471001043.4 – 112827317.2)/5] = 8463.73 
sdy = √ [(358551716.3 – 122132260.4)/5] = 6876.33 
:. SEDmx – my = √ [(8463.73)2/6 + (6876.33)2/6] = 4452.0 
:. t = 175.28/4452.0 
:. t = 0.04 
:. There is a no significant difference in amelogenin m-RNA synthesis 
between Control 14.5 and Wortmannin 14.5  
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f.) Control 16½ and Citral 16.5  
Control 16.5 (x) Citral 16.5 (y) (x)2 (y)2 
114.80 880.40 13179.04 775104.16 
8761.73 23170.50 76767912.59 536872070.3 
29.91 10535.71 894.61 111001185.2 
56.77 4.94 3222.83 24.40 
6080.61 697.47 3697381.97 486464.40 
12819.03 2626.63 164327530.1 6899185.16 
∑x = 27862.85 ∑y = 38404.71 ∑x2 = 278086557.1 ∑y2 = 656034033.6 
Mean = 4643.81 Mean = 6400.76   
 
mx – my = 4643.81 – 6400.76 = 1756.95 
sdx = √ [(278086557.1 - 129389735)/5] = 5453.38 
sdy = √ [(656034033.6 – 245820291.7)/5] = 9057.75 
:. SEDmx – my = √ [(5453.38)2/6 + (9057.75)2/6] = 4316.29 
:. t = 1756.95/4316.29 
:. t = 0.41 
:. No statistical significant difference in amelogenin expression between 
Control 16½ and Citral 16.5  
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g.) Control 16.5 and Wortmannin 16.5  
Control 16.5 (x) Wortmannin 16.5 
(y) 
(x)2 (y)2 
114.80 199.33 13179.04 39732.45 
8761.73 177.05 76767912.59 31346.70 
29.91 946.86 894.61 896543.86 
56.77 82.48 3222.83 6802.95 
6080.61 56.45 3697381.97 3186.60 
12819.03 519.87 164327530.1 270264.82 
∑x = 27862.85 ∑y = 1925.56 ∑y2 = 278086557.1 ∑y2 = 1247877.38 
Mean = 4643.81 Mean = 320.93   
 
mx – my = 4643.81 – 320.93 = 4322.88 
sdx = √ [(278086557.1 - 129389735 )/5] = 5453.38 
sdy = √ [(1247877.38 – 617963.55)/5] = 354.94 
:. SEDmx – my = √ [(5453.38)2/6 + (354.94)2/6] = 2231.04 
:. t = 4322.88/2231.04 
:. t = 1.93 
:. No statistical significant difference between Control 16.5 and 
Wortmannin 16.5  
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2. t-test analysis (laminin α5 expression) 
a.) Control 14.5 and Control 16.5  
Control 14.5 (x) Control 16.5 (y) (x)2 (y)2 
188.97 0.89 35709.66 0.7921 
772941.66 87864.94 5.9x1011 7720247681 
117.30 3499.66 13759.30 12247620.12 
1666.96 43.23 2778755.64 1868.83 
138.43 3970.21 19162.86 15762567.44 
7281.40 464719.29 53018785.96 2.1x1011 
∑x = 780834.72 ∑y = 560098.22 ∑x2 = 5.9x1011 ∑y2 = 2.1x1011 
Mean = 130139.12 Mean = 93349.70   
 
mx – my = 130139.12 – 93349.70 = 36789.42 
sdx = √ [(5.9x1011 – 1.0x1011)/5] = 312532.51 
sdy =  √ [(2.1x1011 – 5.2x1010)/5] = 17760.49 
:. SEDmx – my = √ [(312532.51)2/6 + (17760.49)2/6] = 146753.51 
:. t = 36789.42/146753.51 
:. t = 0.25 
:. There is no significant difference between Control 14.5 and Control 
16.5  
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b.) Citral 14.5 and Citral 16.5  
Citral 14.5 (x) Citral 16.5 (y) (x)2 (y)2 
23854.93 9809.75 569057685.3 96231195.06 
10.26 620469.20 105.27 3.8x1011 
193.47 376.90 37430.64 142053.61 
3.71 92361.25 13.76 8530600502 
29634.70 424.02 878215444.1 179792.96 
6347.62 65536.0 40292279.66 429496.73 
∑x = 60044.69 ∑y = 788977.12 ∑x2 = 1487602959 ∑y2 = 3.8x1011 
Mean = 10007.45 Mean = 131496.19   
 
mx – my = 131496.19 – 10007.45 = 121488.74 
sdx = √ [(1487602959 – 600894132.9)/5] = 13316.97 
sdy = √ [(3.8x1011 – 1.0x1011)/5] = 235054.27 
:. SEDmx – my = √ [(13316.97)2/6 + (235054.27)2/6] = 96114.38 
:. t = 121488.74/96114.38 
:. t = 1.26 
:. There is no significant difference between Citral 14.5 and Citral 16.5  
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c.) Wortmannin 14.5 and Wortmannin 16.5  
Wortmannin 14.5 
(x) 
Wortmannin 16.5 
(y) 
(x)2 (y)2 
43.77 277860.26 1915.81 7.7x1010 
205674.01 46405.24 4.2x1010 2153446299 
721.10 232.50 519841 54056.30 
656301.86 12.27 4.3x1011 150.55 
1.61 28036.14 2.59 786025146.1 
221.78 142.62 49186.37 20340.46 
∑x = 862964.13 ∑y = 352689.03 ∑x2 = 4.2x1011 ∑y2 = 7.9x1010 
Mean = 143827.36 Mean = 58781.51   
 
mx – my = 143827.36 – 58781.51 = 85045.85 
sdx = √ [(4.2x1011 – 1.2x1011)/5] = 243262.1 
sdy = √[(7.9x1010 – 2.0x1010)/5] = 107952.21 
:. SEDmx – my = √[(24326.1)2/6 + (107952.21)2/6] = 108650.91 
:. t = 85045.85/108650.91 
:. t = 0.78 
:. There is no significant difference between Wortmannin 14.5 and 
Wortmannin 16.5  
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d.) Control 14.5 and Citral 14½  
Control 14.5 (x) Citral 14.5 (y) (x)2 (x)2 
188.97 23854.93 35709.66 569057685.3 
772941.66 10.26 5.9x1011 105.27 
117.30 193.47 13759.30 37430.64 
1666.96 3.71 2778755.64 13.76 
138.43 29634.70 19162.86 878215444.1 
7281.40 6347.62 53018785.96 40292279.66 
∑x = 780834.72 ∑y = 60044.69 ∑x2 = 5.9x1011 ∑x2 = 1487602959 
Mean = 130139.12 Mean = 10007.45  
 
mx – my = 130139.12 – 10007.45 = 120131.67 
sdx = √ [(5.9x1011 – 1.0x1011)/5] = 312532.51 
sdy =  √ [(1487602959 – 600894132.9)/5] = 13316.97 
:. SEDmx – my = √ [(312532.51)2/6 + (13316.97)2/6] = 127706.70 
:. t = 0.94 
:. There is no significant difference in laminin expression between 
Control 14.5 and Citral 14½  
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e.) Control 16.5 and Citral 16.5  
Control 16.5 (x) Citral 16.5 (y) (x)2 (y)2 
0.89 9809.75 0.7921 96231195.06 
87864.94 620469.20 7720247681 3.8x1011 
3499.66 376.90 12247620.12 142053.61 
43.23 92361.25 1868.83 8530600502 
3970.21 424.02 15762567.44 179792.96 
464719.29 65536.0 2.1x1011 429496.73 
∑x = 560098.22 ∑y = 788977.12 ∑x2 = 2.1x1011 ∑y2 = 3.8x1011 
Mean = 93349.70 Mean = 131496.19   
 
mx – my = 93349.70 – 131496.19 = 38146.50 
sdx = √ [(2.1x1011 – 5.2x1010)/5] = 17760.49 
sdy = √ [(3.8x1011 – 1.0x1011)/5] = 235054.27  
:. SEDmx – my = √ [(17760.49)2/6 + (235054.27)2/6] = 96234.04 
:. t = 0.40 
:. There is no significant difference in laminin expression between 
Control 16.5 and Citral 16.5  
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f.) Control 14.5 and Wortmannin 14.5  
Control 14.5 (x) Wortmannin 14.5 
(y) 
(x)2 (y)2 
188.97 43.77 35709.66 1915.81 
772941.66 205674.01 5.9x1011 4.2x1010 
117.30 721.10 13759.30 519841 
1666.96 656301.86 2778755.64 4.3x1011 
138.43 1.61 19162.86 2.59 
7281.40 221.78 53018785.96 49186.37 
∑x = 780834.72 ∑y = 862964.13 ∑x2 = 5.9x1011 ∑y2 = 4.2x1011 
Mean = 130139.12 Mean = 143827.36   
 
mx – my = 130139.12 – 143827.36 = 13688.24 
sdx = √ [(5.9x1011 – 1.0x1011)/5] = 312532.51  
sdy = √[(4.2x1011 – 1.2x1011)/5] = 243262.1  
:. SEDmx – my = √[(312532.51)2/6 + (243262.1)2/6] = 16185.40 
:. t = 0.86 
:. There is no significant difference in laminin expression between 
Control 14.5 and Wortmannin 14.5  
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g.) Control 16.5 and Wortmannin 16.5  
Control 16.5 (x) Wortmannin 16.5 
(y) 
(x)2 (y)2 
0.89 277860.26 0.7921 7.7x1010 
87864.94 46405.24 7720247681 2153446299 
3499.66 232.50 12247620.12 54056.30 
43.23 12.27 1868.83 150.55 
3970.21 28036.14 15762567.44 786025146.1 
464719.29 142.62 2.1x1011 20340.46 
∑x = 560098.22 ∑y = 352689.03 ∑x2 = 2.1x1011 ∑y2 = 7.9x1010 
Mean = 93349.70 Mean = 58781.51   
 
mx – my = 93349.70 – 58781.51 = 34568.19 
sdx = √ [(2.1x1011 – 5.2x1010)/5] = 17760.49 
sdy = √[(7.9x1010 – 2.0x1010)/5] = 107952.21 
:. SEDmx – my = √[(17760.49)2/6 + (107952.21)2/6] = 44663.78 
:. t = 0.77 
:. There is no significant difference in laminin expression between 
Control 16.5 and Wortmannin 16.5  
 
 
 
 
 
 
 
 
